Cynthia Arnold - Cabot Independent Director
CBT Stock | USD 94.97 5.12 5.12% |
Director
Dr. Cynthia A. Arnold is Independent Director of the Company. She was Chief Technology Officer, The Valspar Corporationrationration, a global paint and coatings company, January 2011 to May 2017, Chief Technology Officer, Sun Chemical Corporationrationration, a producer of inks, coatings and supplies, pigments, polymers, liquid compounds, solid compounds and application materials, 2004 to December 2010, Vice President of Coatings, Adhesives and Specialty Chemicals Technology, Eastman Chemical Company, a global advanced materials and specialty additives company, 20032004. Management and technology leadership positions, General Electric Company, a high technology industrial leader, 1994 to 2003. Member, Advisory Board, University of Minnesota Dept of Chemical Engineering and Materials Science Member, Materials Advisory Board, Carbon 3D, Inc. Board Member, Minnesota Zoo Dr. Arnold has a depth of global experience in the specialty chemicals industry, particularly in technology and innovation, with an understanding of the value chains in which Cabot participates. since 2018.
Age | 62 |
Tenure | 6 years |
Professional Marks | Ph.D |
Address | Two Seaport Lane, Boston, MA, United States, 02210-2019 |
Phone | 617 345 0100 |
Web | https://www.cabotcorp.com |
Cabot Management Efficiency
The company has Return on Asset of 0.1073 % which means that on every $100 spent on assets, it made $0.1073 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.283 %, implying that it generated $0.283 on every 100 dollars invested. Cabot's management efficiency ratios could be used to measure how well Cabot manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.05 in 2024. Return On Capital Employed is likely to drop to 0.15 in 2024. Non Current Liabilities Other is likely to gain to about 216.1 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 600.9 M in 2024.Similar Executives
Showing other executives | DIRECTOR Age | ||
John Ballbach | RPM International | 60 | |
Michael Goss | Element Solutions | 60 | |
Kirkland Andrews | RPM International | 53 | |
Maria Hilado | H B Fuller | 56 | |
Salvatore Fazzolari | RPM International | 68 | |
William Dempsey | Ashland Global Holdings | 69 | |
Carolyn Pittman | Minerals Technologies | 57 | |
Scott Morrison | Sensient Technologies | 58 | |
Brendan Cummins | Ashland Global Holdings | 69 | |
Sharad Jain | Sensient Technologies | 61 | |
Joseph Breunig | Minerals Technologies | 59 | |
E ONeal | Element Solutions | 69 | |
William Summers | RPM International | 70 | |
Thomas Handley | H B Fuller | 66 | |
Robert Clark | Minerals Technologies | 57 | |
Ruth Kimmelshue | H B Fuller | 58 | |
David Daberko | RPM International | 75 | |
Charlotte Decker | Quaker Chemical | 56 | |
Essie Whitelaw | Sensient Technologies | 72 | |
Daniel Florness | H B Fuller | 57 | |
Fay West | Quaker Chemical | 52 |
Management Performance
Return On Equity | 0.28 | ||||
Return On Asset | 0.11 |
Cabot Leadership Team
Elected by the shareholders, the Cabot's board of directors comprises two types of representatives: Cabot inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cabot. The board's role is to monitor Cabot's management team and ensure that shareholders' interests are well served. Cabot's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cabot's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeff Zhu, Senior Vice President and President Performance Additives business and President Asia Pacific Region | ||
Steven Delahunt, VP Treasurer | ||
Vanessa Craigie, Corporate Director | ||
Sue Rataj, Non-Executive Chairman of the Board | ||
Aaron Johnson, Senior Inkjet | ||
Karen Kalita, Senior Vice President General Counsel | ||
Jennifer Chittick, Health Safety | ||
Jaume Campana, SVP Segment | ||
Erica CPA, CFO VP | ||
Cynthia Arnold, Independent Director | ||
Martin ONeill, Senior Affairs | ||
Juan Enriquez, Independent Director | ||
Douglas Grosso, Independent Director | ||
Matthias Wolfgruber, Independent Director | ||
Lisa Dumont, Principal Accounting Officer, Controller | ||
Sean Keohane, Executive VP and President of Reinforcement Materials Segment | ||
Patricia Hubbard, Senior Vice President, Chief Technology Officer | ||
Karen JD, Senior Counsel | ||
Susan Rataj, Non-Executive Independent Chairman of the Board | ||
Doug Grosso, Independent Director | ||
Mark Wrighton, Independent Director | ||
Jane Bell, Secretary | ||
Erica McLaughlin, Chief Financial Officer, Senior Vice President | ||
Arthur Wood, Senior Officer | ||
Michael Morrow, Independent Director | ||
Christine Yan, Independent Director | ||
William Kirby, Independent Director | ||
Hobart Kalkstein, Senior Vice President and President - Reinforcement Materials Segment, and President, Americas Region | ||
Frank Wilson, Independent Director |
Cabot Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cabot a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.28 | ||||
Return On Asset | 0.11 | ||||
Profit Margin | 0.1 % | ||||
Operating Margin | 0.15 % | ||||
Current Valuation | 6.55 B | ||||
Shares Outstanding | 54.39 M | ||||
Shares Owned By Insiders | 1.10 % | ||||
Shares Owned By Institutions | 96.69 % | ||||
Number Of Shares Shorted | 2.29 M | ||||
Price To Earning | 29.11 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cabot Stock Analysis
When running Cabot's price analysis, check to measure Cabot's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabot is operating at the current time. Most of Cabot's value examination focuses on studying past and present price action to predict the probability of Cabot's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabot's price. Additionally, you may evaluate how the addition of Cabot to your portfolios can decrease your overall portfolio volatility.